Cargando…
Osteopontin as a Tumor Marker in Ovarian Cancer
INTRODUCTION: Ovarian cancer is associated with high morbidity and mortality. This is due to the nonspecific symptoms and no effective screening methods. Currently, carbohydrate antigen-125 (CA125) is used as a tumor biomarker for the diagnosis of ovarian cancer, but it has its own limitations. Henc...
Autores principales: | Rani, Shikha, Sehgal, Alka, Kaur, Jasbinder, Pandher, Dilpreet Kaur, Punia, Rajpal Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025823/ https://www.ncbi.nlm.nih.gov/pubmed/36950209 http://dx.doi.org/10.4103/jmh.jmh_52_22 |
Ejemplares similares
-
Clinical outcome of abdominal sacrocolpopexy
por: Rani, Shikha, et al.
Publicado: (2015) -
Pain, stress, analgesia and postpartum depression: Revisiting the controversy with a randomized controlled trial
por: Kaur, Amrit, et al.
Publicado: (2020) -
Multilocular peritoneal inclusion cyst mimicking an ovarian tumor: A case report
por: Singh, Anju, et al.
Publicado: (2015) -
Potential of Osteopontin in the Management of Epithelial Ovarian Cancer
por: Cerne, Katarina, et al.
Publicado: (2019) -
Dihydrotestosterone in Amyotrophic lateral sclerosis—The missing link?
por: Sawal, Nishit, et al.
Publicado: (2020)